Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

10,628 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,472
Recruiting: 1,283
Ph III recruiting: 130
Growth YoY: +4.1%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,642)

clinicaltrialsPublishedShowing 401–450 of 711 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07294677	CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL(CAVALRY)	recruiting	Phase 1 / Phase 2	104	University of ChicagoOTHER	1	Mar 4, 2026	clinicaltrials
NCT07448324	Orelabrutinib Combined With Rituximab ± Lenalidomide in Response-Adapted Stratified Therapy for Untreated MZL	recruiting	Phase 2	50	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	1	Mar 4, 2026